Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort

Sarink, D (author)

Schock, H (author)

Johnson, T (author)

show more...

Chang-Claude, J (author)

Overvad, K (author)

Olsen, A (author)

Tjonneland, A (author)

Arveux, P (author)

Fournier, A (author)

Kvaskoff, M (author)

Boeing, H (author)

Karakatsani, A (author)

Trichopoulou, A (author)

Vecchia, C (author)

Masala, G (author)

Agnoli, C (author)

Panico, S (author)

Tumino, R (author)

Sacerdote, C (author)

Gils, CH (author)

Peeters, PHM (author)

Weiderpass, E (author)

Karolinska Institutet

Agudo, A (author)

Rodriguez-Barranco, M (author)

Huerta, J (author)

Ardanaz, E (author)

Gil, L (author)

Kaw, KT (author)

Schmidt, JA (author)

Dossus, L (author)

His, M (author)

Aune, D (author)

Riboli, E (author)

Kaaks, R (author)

Fortner, RT (author)

show less...

 (creator_code:org_t)

2018-10-22

2018

English.

In: BMC cancer. - : Springer Science and Business Media LLC. - 1471-2407. ; 18:1, s. 1010-

Related links:

https://bmccancer.bi...

show more...

http://kipublication...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)